MEEDER ASSET MANAGEMENT INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2021$0
-100.0%
190.0%0.00%
Q2 2021$1,0000.0%190.0%0.00%
Q1 2021$1,0000.0%190.0%0.00%
Q4 2020$1,0000.0%190.0%0.00%
Q3 2020$1,000
-50.0%
19
-52.5%
0.00%
Q1 2020$2,000
-50.0%
40
-16.7%
0.00%
Q4 2019$4,000
+100.0%
48
+20.0%
0.00%
Q3 2019$2,0000.0%400.0%0.00%
Q2 2019$2,0000.0%400.0%0.00%
Q1 2019$2,000
-84.6%
40
-87.3%
0.00%
-100.0%
Q4 2018$13,000
-99.8%
315
+129.9%
0.00%0.0%
Q2 2018$6,193,000
+19253.1%
137
-79.0%
0.00%
-66.7%
Q1 2018$32,000
+700.0%
653
+573.2%
0.00%
Q4 2017$4,000
+100.0%
97
+59.0%
0.00%
Q3 2017$2,000
-66.7%
61
-70.2%
0.00%
-100.0%
Q2 2017$6,000
+20.0%
205
+40.4%
0.00%
Q1 2017$5,000
-44.4%
146
-77.0%
0.00%
-100.0%
Q4 2016$9,0006360.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Grace Capital 177,414$14,103,00011.50%
Fernwood Investment Management, LLC 258,012$20,509,0009.81%
Perceptive Advisors 5,865,726$466,266,0009.26%
ArchPoint Investors 186,756$14,845,0004.54%
STANSBERRY ASSET MANAGEMENT, LLC 115,638$9,192,0003.74%
Camber Capital Management LP 730,000$58,028,0002.95%
Profit Investment Management, LLC 46,873$3,726,0002.50%
Casdin Capital, LLC 300,000$23,847,0002.19%
SECTORAL ASSET MANAGEMENT INC 174,594$13,878,0002.07%
Corriente Advisors, LLC 40,000$3,180,0001.71%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders